|
Administration
Should be taken with food. Chew/crush tab & do not swallow whole.
|
|
Contraindications
Haemochromatosis and other Fe accumulation disorders.
|
|
Special Precautions
Patient with history of peritonitis (within the last 3 months), significant gastrointestinal disorders, or major gastrointestinal surgery. Hepatic impairment. Pregnancy and lactation. Monitoring Parameters Monitor serum phosphorus, Ca, and PTH levels.
|
|
Adverse Reactions
Significant: Stool discolouration (black) which may visually mask gastrointestinal bleeding; diarrhoea.
Gastrointestinal disorders: Nausea, vomiting, constipation, dyspepsia, flatulence, tooth and tongue discolouration, dysphagia, gastritis, abdominal pain or discomfort, GERD.
General disorders and administration site conditions: Abnormal product taste, fatigue.
Metabolism and nutrition disorders: Hypercalcaemia, hypocalcaemia.
Nervous system disorders: Headache.
Respiratory, thoracic and mediastinal disorders: Dyspnoea.
Skin and subcutaneous tissue disorders: Pruritus, rash.
|
|
Drug Interactions
May decrease the serum concentrations of doxycycline, cefalexin, aspirin, and levothyroxine; administer these agents at least 1 hour before giving sucroferric oxyhydroxide (dosing interval of interacting agents may vary between countries).
|
|
ATC Classification
V03AE05 - sucroferric oxyhydroxide ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia.
|
Sign Out
